Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

Md L T Vieira, Brian J. Kirby, Isabelle Ragueneau‐Majlessi, Aleksandra Galetin, Jenny Y. Chien, Heidi J. Einolf, Odette A. Fahmi, Volker Fischer, Adrian J. Fretland, K. Grime, Stephen D. Hall, Richard E. Higgs, David R. Plowchalk, R Riley, Eleanore Seibert, Konstantine W. Skordos, Jan Snoeys, Karthik Venkatakrishnan, Timothy Waterhouse, R. Scott Obach, Eva Gil Berglund, L. Zhang, Ping Zhao, K S Reynolds, S-m HuangClinical 2013 · DOI

Abstract

Nine static models (seven basic and two mechanistic) and their respective cutoff values used for predicting cytochrome P450 3A (CYP3A) inhibition, as recommended by the US Food and Drug Administration and the European Medicines Agency, were evaluated using data from 119 clinical studies with orally administered midazolam as a substrate. Positive predictive error (PPE) and negative predictive error (NPE) rates were used to assess model performance, based on a cutoff of 1.25-fold change in midazolam area under the curve (AUC) by inhibitor. For reversible inhibition, basic models using total or unbound systemic inhibitor concentration [I] had high NPE rates (46-47%), whereas those using intestinal luminal ([I]gut) values had no NPE but a higher PPE. All basic models for time-dependent inhibition had no NPE and reasonable PPE rates (15-18%). Mechanistic static models that incorporate all interaction mechanisms and organ specific [I] values (enterocyte and hepatic inlet) provided a higher predictive precision, a slightly increased NPE, and a reasonable PPE. Various cutoffs for predicting the likelihood of CYP3A inhibition were evaluated for mechanistic models, and a cutoff of 1.25-fold change in midazolam AUC appears appropriate.
BibTeX
@inproceedings{vieira2013evaluation,
  author = {Md L T Vieira and Brian J. Kirby and Isabelle Ragueneau‐Majlessi and Aleksandra Galetin and Jenny Y. Chien and Heidi J. Einolf and Odette A. Fahmi and Volker Fischer and Adrian J. Fretland and K. Grime and Stephen D. Hall and Richard E. Higgs and David R. Plowchalk and R Riley and Eleanore Seibert and Konstantine W. Skordos and Jan Snoeys and Karthik Venkatakrishnan and Timothy Waterhouse and R. Scott Obach and Eva Gil Berglund and L. Zhang and Ping Zhao and K S Reynolds and S-M Huang},
  title = {{Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug}},
  booktitle = {Clinical},
  year = {2013},
  doi = {10.1038/clpt.2013.187},
}

Loading related content...

Figure